Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04989504 · ClinicalTrials.gov registry record · Phase 3
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy
A Phase 3 study of Breast Carcinoma and Mastectomy Patient, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- Phase 3
- Development phase
- 216
- Enrollment target
- 20
- Study locations
NCT04989504 is a Phase 3 study of Breast Carcinoma and Mastectomy Patient that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 216 participants, below the 768-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (72% lower). The trial reports 20 study locations across 6 states.
The verdict
NCT04989504, a Phase 3 study of Breast Carcinoma and Mastectomy Patient, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 216 participants
- Enrollment target
- 20
- Study locations
Study Summary
This phase III trial studies how well Mepitel Film works in reducing radiation dermatitis (redness and peeling) in patients with breast cancer during radiation therapy after a mastectomy. Mepitel Film may reduce the severity of skin redness and peeling in the area of radiation.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- DEVICE Wound Dressing Material
Study Locations (20)
Iowa
- McFarland Clinic - Ames - Ames
- Mercy Hospital - Cedar Rapids
- Oncology Associates at Mercy Medical Center - Cedar Rapids
- Mercy Cancer Center-West Lakes - Clive
- Iowa Methodist Medical Center - Des Moines
- Medical Oncology and Hematology Associates-Des Moines - Des Moines
- Mercy Medical Center - Des Moines - Des Moines
Delaware
- Beebe South Coastal Health Campus - Frankford
- Helen F Graham Cancer Center - Newark
- Medical Oncology Hematology Consultants PA - Newark
- Beebe Health Campus - Rehoboth Beach
Maine
- MaineHealth Coastal Cancer Treatment Center - Bath
- Maine Medical Center-Bramhall Campus - Portland
- MaineHealth Cancer Care Center of York County - Sanford
- Maine Medical Center- Scarborough Campus - Scarborough
California
- Fremont - Rideout Cancer Center - Marysville
- Gene Upshaw Memorial Tahoe Forest Cancer Center - Truckee
Maryland
- Anne Arundel Medical Center - Annapolis
- University of Maryland/Greenebaum Cancer Center - Baltimore
Florida
- John Fitzgerald Kennedy Medical Center - Atlantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2022-07-26 |
| Est. Completion | 2029-02-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04989504
The ClinicalTrials.gov registry entry for NCT04989504 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 768-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (72% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04989504 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Iowa, Delaware, Maine.
Frequently Asked Questions
What is clinical trial NCT04989504 about?
NCT04989504 is a clinical study titled "Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy". This phase III trial studies how well Mepitel Film works in reducing radiation dermatitis (redness and peeling) in patients with breast cancer during radiation therapy after a mastectomy. Mepitel Film may reduce the severity of skin redness and peeling in the area of radiation.
What is the current status of trial NCT04989504?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 2022-07-26. Estimated completion is 2029-02-15.
What conditions does trial NCT04989504 study?
This clinical trial studies the following conditions: Breast Carcinoma, Mastectomy Patient.
What interventions are being tested in trial NCT04989504?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Wound Dressing Material (DEVICE).
Who is sponsoring clinical trial NCT04989504?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04989504 being conducted?
This trial has 20 study locations across California, Delaware, Florida, Iowa, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
ACTIVE NOT RECRUITING · Phase 3
-
Breast Cancer WEight Loss Study (BWEL Study)
ACTIVE NOT RECRUITING · Phase 3
-
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
COMPLETED · Phase 3
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.